PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.52%
Negative net income growth while VUZI stands at 11.25%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
13.94%
D&A growth well above VUZI's 22.92%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-23.33%
Negative yoy deferred tax while VUZI stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-93.97%
Both reduce yoy usage, with VUZI at -19.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-93.25%
Negative yoy inventory while VUZI is 80.56%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
23.81%
Lower 'other non-cash' growth vs. VUZI's 100.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-26.67%
Both yoy CFO lines are negative, with VUZI at -38.64%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-36.67%
Both yoy lines negative, with VUZI at -18.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
21.45%
Purchases growth of 21.45% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-40.58%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
73.02%
Growth well above VUZI's 6.90%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-33.15%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-40.34%
Negative yoy issuance while VUZI is 124.06%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-99.61%
We cut yoy buybacks while VUZI is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.